Efficacy and Safety of Triplet Versus Doublet Salvage Therapies Among Patients with Multiple Myeloma (MM) Experiencing Early Relapse: Meta-Analysis of Phase III Randomized Controlled Trials (RCTs)

被引：0
|
作者：
Nooka, Ajay K. [1 ]
Kaufman, Jonathan L. [1 ]
Behera, Madhusmita [2 ]
Gleason, Charise [1 ]
Collins, Hannah [1 ]
Gupta, Vikas A. [1 ]
Boise, Lawrence H. [1 ]
Lonial, Sagar [1 ]
机构：
[1] Emory Univ, Winship Canc Inst, Div BMT, Atlanta, GA 30322 USA
[2] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy and safety of triplet versus doublet salvage therapies among relapsed myeloma patients: Meta-analysis of phase 3 randomized controlled trials.
    Nooka, Ajay K.
    Kaufman, Jonathan L.
    Lonial, Sagar
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Triplet versus doublet combination regimens for the treatment of relapsed or refractory multiple myeloma: A meta-analysis of phase III randomized controlled trials
    Sun, Zhiqiang
    Zheng, Fang
    Wu, Suwan
    Liu, Yanjuan
    Guo, Hehe
    Liu, Yichen
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 113 : 249 - 255
  • [3] Early versus Deferred Treatment for Smoldering Multiple Myeloma: A Meta-Analysis of Randomized, Controlled Trials
    Gao, Minjie
    Yang, Guang
    Tompkins, Van S.
    Gao, Lu
    Wu, Xiaosong
    Tao, Yi
    Hu, Xiaojing
    Hou, Jun
    Han, Ying
    Xu, Hongwei
    Zhan, Fenghuang
    Shi, Jumei
    PLOS ONE, 2014, 9 (10):
  • [4] The Improved Efficacy of Bortezomib Containing Induction Regimens (BCIR) Versus Non-Bortezomib Containing Induction Regimens (NBCIR) in Transplant-Eligible Patients with Multiple Myeloma (MM): Meta-Analysis of Phase III Randomized Controlled Trials (RCTs)
    Nooka, Ajay K.
    Kaufman, Jonathan L.
    Behera, Madhusmita
    Gleason, Charise
    Langston, Amelia
    Steuer, Conor Ermst
    Flowers, Christopher R.
    Boise, Lawrence H.
    Lonial, Sagar
    BLOOD, 2011, 118 (21) : 1709 - 1710
  • [5] Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients
    Botta, Cirino
    Ciliberto, Domenico
    Rossi, Marco
    Staropoli, Nicoletta
    Cuce, Maria
    Galeano, Teresa
    Tagliaferri, Pierosandro
    Tassone, Pierfrancesco
    BLOOD ADVANCES, 2017, 1 (07) : 455 - 466
  • [6] Safety and efficacy of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis of phase III randomized controlled trials
    Paiva, L. V.
    Providencia, R.
    Faustino, A. C.
    Barra, S.
    Dinis, P.
    Caetano, F.
    Almeida, I.
    Botelho, A. M.
    Leitao-Marques, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S284 - S284
  • [7] Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Qiao, Shu-Kai
    Guo, Xiao-Nan
    Ren, Jin-Hai
    Ren, Han-Yun
    CHINESE MEDICAL JOURNAL, 2015, 128 (09) : 1215 - 1222
  • [8] Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Qiao Shu-Kai
    Guo Xiao-Nan
    Ren Jin-Hai
    Ren Han-Yun
    中华医学杂志英文版, 2015, 128 (09) : 1215 - 1222
  • [9] Efficacy and safety of daratumumab in the treatment of relapsed/refractory multiple myeloma: A meta-analysis of randomized controlled trials
    Huang, Zeng-Yi
    Jin, Xiao-Qin
    Liang, Qi-Lian
    Zhang, Ding-Yue
    Han, Han
    Wang, Zhen-Wei
    MEDICINE, 2023, 102 (38) : E35319
  • [10] Tolerability in Patients with Multiple Myeloma Treated with Daratumumab: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials
    Htut, Thura Win
    Win, Myint Aung
    Swarup, Sriman
    Sultan, Anita
    Adhikari, Nimesh
    Phyu, Ei Moe
    Dash, Akshar
    Han, Myat Min
    Myat, Yin Mon
    Awasthi, Sanjay
    Tijani, Lukman
    D'Cunha, Nicholas
    Quick, Donald P.
    Thein, Kyaw Zin
    BLOOD, 2019, 134
12345